Inventor · disambiguated record
Amadeo Mark Parissenti
Also filed as: PARISSENTI AMADEO · PARISSENTI AMADEO MARK
6 granted patents·4 pending applications·3 citations·filing 2004–2021
68Inventor score
Top patents by PatentIndex Score
10 records- 0160US2022028489A1Method for determining efficacy of chemotherapy treatment for a subjectRNA DIAGNOSTICS INC·Filed 2021·Application pending·0 cites
- 0257US10385400B2Methods and kits for monitoring response to radiation therapies in cancerRNA DIAGNOSTICS INC·Filed 2013·Granted Aug 20, 2019·1 cites·16 claims
- 0356US7371780B2Use of calphostin C to treat drug-resistant tumor cellsPARISSENTI AMADEO·Filed 2004·Granted May 13, 2008·2 cites·17 claims
- 0455US11031096B2Method for determining efficacy of chemotherapy treatment for a subjectRNA DIAGNOSTICS INC·Filed 2013·Granted Jun 8, 2021·0 cites·12 claims
- 0552US10731222B2RNA disruption assay for predicting survivalRNA DIAGNOSTICS INC·Filed 2014·Granted Aug 4, 2020·0 cites·16 claims
- 0650US2010317001A1Method of using tumour rna integrity to measure response to chemotherapy in cancer patientsLAURENTIAN UNIVERSITY·Filed 2008·Application pending·0 cites
- 0742US2016077051A1Method of using tumour rna integrity to measure response to chemotherapy in cancer patientsLAURENTIAN UNIVERSITY·Filed 2015·Application pending·0 cites
- 0834US2014274927A1TNF-Related Biomarkers For Assessing Cancer Cell Response To Treatment With Taxane And/Or Anthracycline DrugsPARISSENTI AMADEO MARK·Filed 2014·Application pending·0 cites
- 0933US10590463B2Diagnostic methods and kits for monitoring response to chemotherapy in ovarian cancerPARISSENTI AMADEO MARK·Filed 2011·Granted Mar 17, 2020·0 cites·12 claims
- 1031US7588903B2Use of isogenic drug-resistant cell lines to determine the sequence of chemotherapeutic drug treatmentPARISSENTI AMADEO·Filed 2004·Granted Sep 15, 2009·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Amadeo Mark Parissenti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →